Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Julphar
Citi
Daiichi Sankyo
Johnson and Johnson
Federal Trade Commission
Express Scripts
Harvard Business School
Dow

Generated: October 23, 2017

DrugPatentWatch Database Preview

VANDAZOLE Drug Profile

« Back to Dashboard

What is the patent landscape for Vandazole, and when can generic versions of Vandazole launch?

Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

Summary for Tradename: VANDAZOLE

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list110
Patent Applications: see list8,587
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VANDAZOLE at DailyMed

Pharmacology for Tradename: VANDAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms
VANDAZOLE
metronidazole
GEL;VAGINAL021806-001May 20, 2005BXRXNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expiration for: VANDAZOLE

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe
VANDAZOLE
► Subscribe
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
US Army
Julphar
Citi
US Department of Justice
Merck
Baxter
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot